99mTc-3PRGD2, a new SPECT tracer that targets integrin xvB3 receptor, is sensitive for the detection of lung cancer, according to a study published in the May issue of The Journal of Nuclear Medicine.
Rates of death in the U.S. from all cancers for men and women continued to decline between 2004 and 2008, according to the “Annual Report to the Nation on the Status of Cancer,” published online in Cancer on March 28.
The FDA has sent a letter to Cell>Point indicating agreement on a Special Protocol Assessment for the company's Phase III pivotal clinical study of technetium-99m-EC-G in lung cancer.
The University of Wisconsin Carbone Cancer Center in Madison has enrolled the first patient in a Phase 1-2 PET imaging trial of I-124-CLR1404 (LIGHT, Novelos Therapeutics), a cancer-targeted PET imaging agent, in patients with advanced non-small cell lung cancer (NSCLC).
Advanced cancer biomarker research may well be moving beyond the realm of diagnostic to preventive medicine.
The use of PET imaging increased rapidly from 2004 through 2008 among Medicare beneficiaries diagnosed with cancer, according to a study published in the January issue of Journal of the American College of Radiology. The researchers surmised that PET primarily serves as an additional, rather than replacement, imaging exam.
The CHEST Foundation has awarded a Roswell Park Cancer Institute research team a $100,000 grant to develop a blood test to help diagnose lung cancer in patients before they undergo a biopsy.
Baseline whole-body tumor burden provided a prognostic measurement in patients with Stage IV nonsurgical non-small-cell lung cancer with low interobserver variability, according to a study published in the January 2012 issue of Academic Radiology.
Boston University School of Medicine has received a $13.6 million grant to be the lead institution in a study aimed at developing technologies for the early detection of lung cancer. The five-year multi-site, multi-phase study that will focus on active military personnel and veterans is funded by the U. S. Department of Defense Lung Cancer Research Program.
Over the next decade, the population of cancer survivors over 65 years of age will increase by approximately 42 percent, according to a report published in the October issue of Cancer Epidemiology, Biomarkers & Prevention.
Post-treatment imaging with PET scans has shown promise in predicting which patients with stage II and III inoperable non-small cell lung cancer have aggressive tumors and need additional treatment, according to the preliminary study results reported at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Miami.
A new method to detect regional lymph node metastases in patients with non-small cell lung cancer using a virtual fly-through 3D 18F-FDG PET/CT bronchoscopy has been shown to have high diagnostic accuracy, according to research published in the October issue of Journal of Nuclear Medicine.
A newer type of MRI scan, diffusion-weighted MRI, can better differentiate benign lung lesions from those which are cancerous, and therefore, could be used to prevent unnecessary surgery by enabling more accurate diagnosis of the disease, based on a study presented Sept. 25 at the European Respiratory Society's annual congress in Amsterdam.
The rates of new lung cancer cases in the U.S. dropped among men in 35 states and among women in six states between 1999 and 2008, according to a report by the Centers for Disease Control and Prevention (CDC). Among women, lung cancer incidence decreased nationwide between 2006 and 2008, after increasing steadily for decades. Smoking cessation fueled the decline and other data have suggested CT screening could motivate smokers to quit.
Image-guided thermal ablation of lung malignancies is on the rise and appears to offer a safe choice for a subset of non-surgical candidates. However, additional clinical studies are needed to demonstrate the efficacy of the procedure in comparison with other treatments, according to a review article published in the September issue of Radiology.
A retrospective examination of 5,201 high-risk patients undergoing annual screening CT studies for five years found unsuspected extrapulmonary malignancies in 0.5 percent of the cohort, according to a study published online Aug. 9 in Radiology.
Researchers found the newly-developed radiopharmaceutical C-4DST safe and effective for imaging brain tumors in a pilot study published Aug. 1 in the Journal of Nuclear Medicine.
The success of the National Lung Screening Trial (NLST) has not closed the book on lung cancer screening. Instead, it has spurred a host of questions related to overdiagnosis, costs and the potential for other screening methods, according to an article and editorial published Aug. 4 in New England Journal of Medicine. NLST researchers and the editorialist reached the same conclusion: screening CT is not ready for prime time.
Males are significantly more likely to die from most cancers than females, a risk that mirrors a higher incidence of cancer among men, according to a study published in the August issue of Cancer Epidemiology, Biomarkers & Prevention.
Researchers found low fetal radiation exposures in a retrospective study assessing the effects of F-FDG PET studies performed on pregnant patients with cancer, according to findings published in the July issue of the Journal of Nuclear Medicine.
|
RSS 
